MICA and neoplasm: Treatment of MDA-MB-231 xenografted nude mice with mAb04-MICA was more effective than that with mAb04 in inhibiting tumor growth, achieving 36.28% and 77.43% tumor growth inhibition at doses of 1 and 5 mg/kg compared to 15.13% and 55.71% for mAb04, respectively.